• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER KNEE CREATIONS, INC. ACCUFILL 5CC; CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER KNEE CREATIONS, INC. ACCUFILL 5CC; CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER Back to Search Results
Model Number N/A
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Date 07/18/2013
Event Type  Injury  
Manufacturer Narrative
This complaint is based on a clinical study review.The investigation is still in-progress.A supplemental mdr will be submitted once the investigation is completed.Not available.
 
Event Description
Not related to device or procedure adverse event.
 
Manufacturer Narrative
The patient involved in this complaint was a (b)(6) female collegiate athlete at the time she saw dr.(b)(6) on (b)(6) 2011.The patient reported bilateral anterior knee pain beginning in 2006.An arthroscopy with chondroplasty of the left patella with loose body removal was performed in (b)(6) 2007.She was diagnosed with patellar malalignment and underwent tuberosity medialization with lateral release on the left knee (b)(6) 2010.The operative notes state there was a 20mm diameter grade 3 lesion of the patella at the surgery.In (b)(6) 2011 subject underwent hardware removal.During a clinical visit with dr.(b)(6) on (b)(6) 2011, subject stated she had no new injury but had increasing anterior knee pain.The patient underwent suchondroplasty (b)(6) 2012 to treat a bone marrow lesion in the central portion of the patella and was enrolled in the (b)(4) clinical study.The patient continued to have persistently symptomatic patellar chondrosis despite normal tt-tg distance.Dr.(b)(6) assessed this adverse event as mild and not related to the subchondroplasty procedure or device.The patient elected to undergo autologous chondrocyte implantation with straight anteriorization of the tubercle of the left knee on (b)(6) 2012.During subject post-operative clinical visit on (b)(6) 2012, dr.(b)(6) noted symptomatic patellar chondrosis adverse event to be resolved.However, during a clinical visit with dr.(b)(6) on (b)(6) 2013, the subject reported she had developed increased anterior pain and crunching sensation following an incident while playing basketball.Dr.(b)(6) assessed this adverse event as mild and not related to the original subchondroplasty procedure or device.Dr.(b)(6) also noticed less quadriceps girth in her left vs right leg.Dr.(b)(6) completed a diagnostic arthroscopy on (b)(6) 2013 with partial synovectomy, scar tissue removal, along with removal of tuberosity deep hardware from the previous surgery.Dr.(b)(6) noted that the site of the previously performed autologous chondrocyte transplantation appeared to be well filled an integrated with only minor fraying and softening of the repair tissue.Dr.(b)(6) noted increased synovial tissue in the parapatellar region and scar tissue which may have been a contributing factor to her pain.During the patient's post-operative clinical visit on (b)(6) 2013, subject reported a decrease in grinding and dr.(b)(6) believed patient's adverse event of increased parapatellar synovium and scar to be resolved.Imaging and the operative notes for the subchondroplasty procedure were not available at the time of this investigation so it is not known if the recommended surgical technique was followed or what volume of accufill was used.The patient symptoms associated with the increased synovium and scar tissue appear to be most related to prior autologous chondrocyte implantation procedure which was performed through an open procedure with a 10 cm incision.
 
Event Description
After several previous left knee procedures, including subchondroplasty, subject continued to have persistently symptomatic patellar chondrosis and underwent autologus chondrocyte implantation with straight anteriorization of the tubercle of the left knee on (b)(6) 2012.During a clinical visit with dr (b)(6) on (b)(6) 2013, the subject reported she had developed increased anterior pain and crunchong of patellar carticel.Dr (b)(6) completed a diagnostic arthroscopy with partial synovectomy, scar tissue removal, along with removal of tuberosity deep hardware for this subject on (b)(6) 2013 due to subject's patellofemoral activity-related pain with history of carticel implant to the patella.During subject on (b)(6) 2013 due to subject's patellofemoral activity-related pain with history of carticel implant to the patella.During subject's post-operative clinical visit on (b)(6) 2013, subject reported a decrease in grinding and dr.(b)(6) believed subject's mild adverse event(not related to device or procedure) to be resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUFILL 5CC
Type of Device
CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER
Manufacturer (Section D)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
Manufacturer (Section G)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
Manufacturer Contact
shari bailey
841 springdale drive
exton, PA 19341
4848794543
MDR Report Key6142059
MDR Text Key61344585
Report Number3008812173-2016-00032
Device Sequence Number1
Product Code MQV
Combination Product (y/n)N
PMA/PMN Number
PN/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number201.050
Device Lot NumberN/A
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/07/2016
Initial Date FDA Received12/02/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/30/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age25 YR
Patient Weight87
-
-